{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["3\u2019,4\u2019,5,7-tetrahydroxyflavone", "IgE-independent MC activation", "SPP1", "mast cell", "pseudo-anaphylaxis"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "37339357", "DateCompleted": {"Year": "2023", "Month": "12", "Day": "06"}, "DateRevised": {"Year": "2023", "Month": "12", "Day": "16"}, "Article": {"ArticleDate": [{"Year": "2023", "Month": "07", "Day": "03"}], "Language": ["eng"], "ELocationID": ["10.1080/08923973.2023.2228478"], "Journal": {"ISSN": "1532-2513", "JournalIssue": {"Volume": "45", "Issue": "6", "PubDate": {"Year": "2023", "Month": "Dec"}}, "Title": "Immunopharmacology and immunotoxicology", "ISOAbbreviation": "Immunopharmacol Immunotoxicol"}, "ArticleTitle": "Secreted phosphoprotein 1 regulates natural compound 3',4',5,7-tetrahydroxyflavone to inhibit mast cell-mediated allergic inflammation.", "Pagination": {"StartPage": "672", "EndPage": "681", "MedlinePgn": "672-681"}, "Abstract": {"AbstractText": ["Mast cells (MCs) are important effector cells in anaphylaxis and anaphylactic disease. 3',4',5,7-tetrahydroxyflavone (THF) presents in many medicinal plants and exerts a variety of pharmacological effects. In this study, we evaluated the effect of THF on C48/80-induced anaphylaxis and the mechanisms underlying its effects, including the role of secreted phosphoprotein 1 (SPP1), which has not been reported to IgE-independent MC activation.", "THF inhibited C48/80-induced Ca<sup>2+</sup> flow and degranulation <i>via</i> the PLC\u03b3/PKC/IP3 pathway <i>in vitro</i>. RNA-seq showed that THF inhibited the expression of SPP1 and downstream molecules. SPP1 is involved in pseudo-anaphylaxis reactions. Silencing SPP1 affects the phosphorylation of AKT and P38. THF suppressed C48/80-induced paw edema, hypothermia and serum histamine, and chemokines release <i>in vivo</i>.", "Our results validated SPP1 is involved in IgE-independent MC activation anaphylactoid reactions. THF inhibited C48/80-mediated anaphylactoid reactions both <i>in vivo</i> and <i>in vitro</i>, suppressed calcium mobilization and inhibited SPP1-related pathways."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Pharmacy, Xi'an Jiaotong University, Xi'an, Shaanxi, China."}], "LastName": "Hu", "ForeName": "Shiling", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Pharmacy, Xi'an Jiaotong University, Xi'an, Shaanxi, China."}], "LastName": "Wang", "ForeName": "Jue", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Pharmacy, Xi'an Jiaotong University, Xi'an, Shaanxi, China."}], "LastName": "Bai", "ForeName": "Haoyun", "Initials": "H"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Pharmacy, Xi'an Jiaotong University, Xi'an, Shaanxi, China."}], "LastName": "Feng", "ForeName": "Chaohua", "Initials": "C"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Pharmacy, Xi'an Jiaotong University, Xi'an, Shaanxi, China."}], "LastName": "Zhou", "ForeName": "Zhenqi", "Initials": "Z"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Pharmacy, Xi'an Jiaotong University, Xi'an, Shaanxi, China."}], "LastName": "Xue", "ForeName": "Zhuoyin", "Initials": "Z"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Pharmacy, Xi'an Jiaotong University, Xi'an, Shaanxi, China."}], "LastName": "Zhang", "ForeName": "Wen", "Initials": "W"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Pharmacy, Xi'an Jiaotong University, Xi'an, Shaanxi, China."}], "LastName": "Zhang", "ForeName": "Yongjing", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Pharmacy, Xi'an Jiaotong University, Xi'an, Shaanxi, China."}], "LastName": "Wang", "ForeName": "Nan", "Initials": "N"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Pharmacy, Xi'an Jiaotong University, Xi'an, Shaanxi, China."}], "LastName": "He", "ForeName": "Langchong", "Initials": "L"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "Immunopharmacol Immunotoxicol", "NlmUniqueID": "8800150", "ISSNLinking": "0892-3973"}, "ChemicalList": [{"RegistryNumber": "KUX1ZNC9J2", "NameOfSubstance": "Luteolin"}, {"RegistryNumber": "106441-73-0", "NameOfSubstance": "Osteopontin"}, {"RegistryNumber": "37341-29-0", "NameOfSubstance": "Immunoglobulin E"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["chemically induced", "drug therapy"], "DescriptorName": "Anaphylaxis"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Luteolin"}, {"QualifierName": ["metabolism", "pharmacology"], "DescriptorName": "Osteopontin"}, {"QualifierName": [], "DescriptorName": "Mast Cells"}, {"QualifierName": ["metabolism"], "DescriptorName": "Inflammation"}, {"QualifierName": [], "DescriptorName": "Cell Degranulation"}, {"QualifierName": ["metabolism"], "DescriptorName": "Immunoglobulin E"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "2023", "Month": "12", "Day": "6", "Hour": "6", "Minute": "42"}, {"Year": "2023", "Month": "6", "Day": "20", "Hour": "19", "Minute": "15"}, {"Year": "2023", "Month": "6", "Day": "20", "Hour": "15", "Minute": "23"}], "PublicationStatus": "ppublish", "ArticleIdList": ["37339357", "10.1080/08923973.2023.2228478"]}}], "PubmedBookArticle": []}